Home / Pharma Healthcare / China Biological Safety Testing Market Research Report 2016

China Biological Safety Testing Market Research Report 2016

  • Id : RNR-22221
  • Category : Pharma Healthcare
  • Publish Date : 11-Oct
  • Pages : 119
  • Format : PDF
License Type

Sales, means the sales volume of Biological Safety Testing
Revenue, means the sales value of Biological Safety Testing

This report studies Biological Safety Testing in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering
    Charles River Laboratories International, Inc.
    Lonza Group
    Sigma-Aldrich Corporation
    SGS S.A.
    Wuxi Pharmatech (Cayman) Inc
    Avance Biosciences Inc.
    Bsl Bioservice
    Cytovance Biologics, Inc.
    Merck & Co., Inc.
    Toxikon Corporation

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into
    Adventitious Agents Detection Test
    Bioburden Testing
    Cell Line Authentication And Characterization Tests
    Endotoxin Tests
    Residual Host Contaminant Detection Tests
    Sterility Testing
    Other Tests (Efficacy Tests, Toxicity Tests, Stability Tests)
Split by Application, this report focuses on consumption, market share and growth rate of  Biological Safety Testing in each application, can be divided into
    Blood & Blood Products
    Cellular & Gene Therapy Products
    Stem Cell Products
    Tissues & Tissue Products
    Vaccines and Therapeutics